Editas Medicine (NQ: EDIT )
3.790
-0.290
(-7.11%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 22, 2024
Add to My Watchlist
Headline News about Editas Medicine
![](https://cdn.benzinga.com/files/images/story/2024/08/08/Dati-deludenti-sulloccupazione-USA-e-i-m.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2020/03/gene_editing_a_1600.jpg)
![](https://investorplace.com/wp-content/uploads/2021/02/crispr-genetic-editing.jpg)
![](https://investorplace.com/wp-content/uploads/2019/07/biotech1600gene.jpg)
![](https://investorplace.com/wp-content/uploads/2020/03/gene_editing_c_1600.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.png?width=1200&height=800&fit=crop)
Unveiling 5 Analyst Insights On Editas Medicine
June 18, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.png?width=1200&height=800&fit=crop)
The Latest Analyst Ratings For Editas Medicine
February 29, 2024
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2020/03/gene_editing_c_1600.jpg)
![](https://investorplace.com/wp-content/uploads/2021/09/undervalued-stocks.jpg)
![](https://g.foolcdn.com/editorial/images/776607/person-in-a-lab-looking-through-a-microscope.jpg)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://g.foolcdn.com/editorial/images/768106/three-investors-look-at-papers.jpg)
![](https://g.foolcdn.com/editorial/images/767454/physician-giving-a-high-five-to-a-young-patient.jpg)
![](/next-assets/images/schema-image-default.png)
Earnings Outlook For Editas Medicine
February 27, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.png?width=1200&height=800&fit=crop)
The Latest Analyst Ratings for Editas Medicine
December 12, 2023
Via Benzinga
![](https://g.foolcdn.com/editorial/images/767772/scientist-injecting-samples-into-test-tubes.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/02/28/image21.jpeg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2018/11/Stock-biotech-011-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/02/28/advance_auto_parts_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/762022/physician-shaking-patients-hand.jpg)
![](https://g.foolcdn.com/editorial/images/761796/scientist-studies-test-tube.jpg)
![](https://investorplace.com/wp-content/uploads/2022/07/healthcare-1600.jpg)
![](https://g.foolcdn.com/editorial/images/761086/smart-investor-looking-for-stocks-to-buy-getty.jpg)
![](https://investorplace.com/wp-content/uploads/2022/02/gene-edit.png)
![](https://g.foolcdn.com/editorial/images/759688/scientist-configures-tilting-machine.jpg)
![](https://g.foolcdn.com/editorial/images/758926/scientists-lab-testing-blood-draw.jpg)
![](https://talkmarkets.com/images/logos/talkmarkets.png)
![](https://g.foolcdn.com/editorial/images/756568/physician-giving-a-high-five-to-a-young-patient.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.